Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Reiss

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Food and Drug Law Journal|January 1, 1997
Commentary on payment and reimbursement issues affecting the marketing of drugs, medical devices, and biologics, with emphasis on the anti-kickback statute and Stark IIJ B Reiss
Trends in Health Care, Law & Ethics|January 1, 1993
The doctrine of informed consentJ B Reiss
Proceedings of the Royal Society of Medicine|June 1, 1977
Academic general practice: is it relevant?B B Reiss
Employee Benefits Journal|February 9, 1986
Some legal issues in managing health care costsJ B Reiss
Health Services Research|January 1, 1980
A conceptual model of the case-based payment scheme for New Jersey hospitalsJ B Reiss
Diabetes Technology & Therapeutics|April 11, 2003
How to get paid for a new diabetes productJohn B Reiss
American Journal of Health Planning|December 13, 1977
Economic impact analysis for certificate of need applicationsJ B Reiss
Diabetes Technology & Therapeutics|April 11, 2003
The market for new diabetes products and the role of third-party payorsJohn B Reiss
Current Rheumatology Reports|August 21, 2009
Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosusAllison B Reiss
American Journal of Alzheimer'S Disease and Other Dementias|April 23, 2005
Cholesterol and apolipoprotein E in Alzheimer's diseaseAllison B Reiss
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Food and Drug Law Journal|January 1, 1997
Commentary on payment and reimbursement issues affecting the marketing of drugs, medical devices, and biologics, with emphasis on the anti-kickback statute and Stark IIJ B Reiss
Trends in Health Care, Law & Ethics|January 1, 1993
The doctrine of informed consentJ B Reiss
Proceedings of the Royal Society of Medicine|June 1, 1977
Academic general practice: is it relevant?B B Reiss
Employee Benefits Journal|February 9, 1986
Some legal issues in managing health care costsJ B Reiss
Health Services Research|January 1, 1980
A conceptual model of the case-based payment scheme for New Jersey hospitalsJ B Reiss
Diabetes Technology & Therapeutics|April 11, 2003
How to get paid for a new diabetes productJohn B Reiss
American Journal of Health Planning|December 13, 1977
Economic impact analysis for certificate of need applicationsJ B Reiss
Diabetes Technology & Therapeutics|April 11, 2003
The market for new diabetes products and the role of third-party payorsJohn B Reiss
Current Rheumatology Reports|August 21, 2009
Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosusAllison B Reiss
American Journal of Alzheimer'S Disease and Other Dementias|April 23, 2005
Cholesterol and apolipoprotein E in Alzheimer's diseaseAllison B Reiss
Pageof 21